Huhn Stephen L. - Insider Non-Derivative Transactions at Contineum Therapeutics, Inc. (CTNM) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 13, 2024, Huhn Stephen L.'s relationship to Contineum Therapeutics, Inc. (CTNM) is Officer (CMO & Sr VP, Clinical Dev.), and currently has 12,800 shares of Class A Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CTNM insiders.
Data Source: SEC.
Huhn Stephen L. - Insider Non-Derivative Transactions at CTNM
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 14, 2024 | M -- (Class A Common Stock) | 12800 | 1.01 | 12800 |